Tuesday, November 24, 08:25 am IST
Hot Searches:  mukesh ambanisugarforbes rich list
| Feedback
Moneycontrol » News Center » Business » Earnings
Glenmark Pharma Q4 cons PAT Rs 219 cr
Published on Mon, Apr 28, 2008 at 11:40   |  Updated at Mon, Apr 28, 2008 at 15:47  |  Source : CNBC-TV18

Glenmark Pharma has announce its fourth quarter results. The company's Q4 consolidated PAT Rs 219 crore versus Rs 63 crore.

Its consolidated revenues were up at Rs 582 crore versus Rs 339.1 crore.


Its Generic Arm net sales were at Rs 260 crore versus Rs 120 crore.

Particulars Mar-08 Dec-07 Sep-07 Jun-07
Net Sales / Interest Earned / Operating Income 396.898 433.579 279.267 262.947
Other Income 15.008 2.26 1.694 1.084
Total Income 411.905 435.839 280.961 264.031
Expenditure -281.439 -238.634 -182.47 -188.434
Operating Profit 130.466 197.205 98.491 75.598
Interest -9.144 -11.764 -10.871 -9.352
Profit Before Depreciation and Tax 121.322 185.441 87.62 66.246
Depreciation -8.17 -7.776 -7.506 -5.991
Profit before Tax 113.153 177.665 80.115 60.255
Tax 16.988 -31.238 -16.251 -11.663
Net Profit 130.141 146.427 63.864 48.592
Equity Capital 24.873 24.686 24.394 24.212

Important Links Today:  Leadership Wall    Chat Calendar    The 10 List   
WHAT OTHERS LIKE
  • Most Read
  • Most Viewed
©Network 18, 2009. All Rights Reserved